Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05946031 · ClinicalTrials.gov registry record · Early Phase 1
Testing the ETM: Examination and Comparison of Different Methods
A Early Phase 1 study of Cigarette Smoking, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 87
- Enrollment target
- 1
- Study location
NCT05946031: Completed Early Phase 1 study of Cigarette Smoking, sponsored by Virginia Polytechnic Institute and State University.
NCT05946031 is a Early Phase 1 study of Cigarette Smoking that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 87 participants, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05946031, a Early Phase 1 study of Cigarette Smoking, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 87 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.
Primary Outcome
Participants will complete purchasing trials in an Experimental Tobacco Marketplace (ETM) with cigarettes increasing in price. Other product prices in the ETM will remain constant. To obtain dependent measures of demand, participants' purchasing of the price-manipulated commodity in the ETM task will be fit to a modified exponential equation to quantify the relationship between the price of each commodity and purchasing: Q=Q0\*10k(exp(-αQ0C)-1) where Q is purchasing of the commodity, C is the pr
Conditions Studied
Interventions
- DRUG Reat ETM
- DRUG Hypothetical ETM
Study Locations (1)
Virginia
- Fralin Biomedical Research Institute - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 87 participants |
| Start Date | 2024-07-28 |
| Est. Completion | 2025-08-14 |
| Phase | Early Phase 1 |
What the finished NCT05946031 record still lists
NCT05946031 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 87 participants, a relatively small participant target, below the 174-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (50% lower).
The record links to 1 condition, with Cigarette Smoking appearing as the primary indexed condition, and to 2 interventions - of which Reat ETM is the first listed.
NCT05946031 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT05946031 about?
NCT05946031 is a clinical study titled "Testing the ETM: Examination and Comparison of Different Methods". This study will experimentally assess the comparability of in-lab and remote procedures with hypothetical and real ETM purchase outcomes.
What is the current status of trial NCT05946031?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 87 participants. The study started on 2024-07-28. Estimated completion is 2025-08-14.
What conditions does trial NCT05946031 study?
This clinical trial studies the following conditions: Cigarette Smoking.
What interventions are being tested in trial NCT05946031?
The interventions under investigation include: Reat ETM (DRUG), Hypothetical ETM (DRUG).
Who is sponsoring clinical trial NCT05946031?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05946031 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05946031's enrollment target sits among peer trials
87 23rd of 45 higher than 23 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Cannabis on Cigarette Use Behavior
RECRUITING · Phase 1
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Beta-Adrenergic Modulation of Drug Cue Reactivity
RECRUITING · Phase 4
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03292601 · 87 participants · NA
Brace Monitoring for Adolescent Idiopathic Scoliosis (AIS)
- NCT04291105 · 87 participants · Phase 2
Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
- NCT04565795 · 87 participants · NA
Safety and Device Performance of the Uriprene® Degradable Temporary Ureteral Stent Following Uncomplicated Ureteroscopy
- NCT05607004 · 87 participants · Phase 2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI